Print

DARA BioSciences, Inc. Reports on SurgiVision, Inc.'s Filing of a Registration Statement With the Securities and Exchange Commission for an Initial Public Offering (IPO)  
12/23/2009 10:13:48 AM

Bookmark and Share

RALEIGH, N.C., Dec. 23, 2009 (GLOBE NEWSWIRE) -- DARA BioSciences, Inc. (Nasdaq:DARA), announced today that SurgiVision, Inc., a privately held company of which DARA owns approximately 2,200,000 shares and warrants to purchase an additional 405,000 shares, has filed a registration statement with the Securities and Exchange Commission (SEC) covering the initial public offering of its common stock. SurgiVision's registration statement, which was filed on December 23, 2009, may be accessed through the SEC's website at www.sec.gov.

//-->